Infrequent Detection of KI, WU and MC Polyomaviruses in Immunosuppressed Individuals with or without Progressive Multifocal Leukoencephalopathy
2011

Infrequent Detection of New Polyomaviruses in Immunosuppressed Individuals

Sample size: 269 publication Evidence: moderate

Author Information

Author(s): Dang Xin, Bialasiewicz Seweryn, Nissen Michael D., Sloots Theo P., Koralnik Igor J., Tan Chen S.

Primary Institution: Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America

Hypothesis

What is the prevalence of KI, WU, and MCPyV polyomaviruses in immunosuppressed individuals with or without Progressive Multifocal Leukoencephalopathy?

Conclusion

The study found that KI, WU, and MCPyV polyomaviruses are rarely detected in immunosuppressed individuals, suggesting they do not play a significant role in the pathogenesis of Progressive Multifocal Leukoencephalopathy.

Supporting Evidence

  • Distinct PCR tests detected low levels of MCPyV DNA only in 1 out of 269 samples.
  • Laboratory 1 and Laboratory 2 did not detect KIPyV and WUPyV in any of the samples tested.
  • Only one positive detection of MCPyV was found in the CSF from the immunosuppressed group.

Takeaway

The researchers looked for certain viruses in sick people but found them very rarely, which means these viruses probably don't cause the illness they were studying.

Methodology

The study analyzed cerebrospinal fluid, blood, and bone marrow samples from 123 patients using PCR tests to detect the presence of the polyomaviruses.

Potential Biases

Potential biases may arise from the selection of patient samples and the varying sensitivity of PCR assays.

Limitations

The study's findings may be influenced by geographical diversity and differences in laboratory methods used in various studies.

Participant Demographics

The study included 123 adult patients, comprising HIV-positive individuals with and without Progressive Multifocal Leukoencephalopathy, HIV-negative individuals with Progressive Multifocal Leukoencephalopathy, multiple sclerosis patients, and other immunosuppressed patients.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016736

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication